Regulation 217C Amendment of regulation 307 (corrective statement)F1I1
In regulation 307—
in paragraph (1)(a), after “subject of the notice” insert—
“in—
(i)Great Britain;
(ii)Northern Ireland; or
(iii)both Great Britain and Northern Ireland”;
in paragraph (1)(b), after “that advertisement” insert—
“in—
(i)Great Britain;
(ii)Northern Ireland; or
(iii)both Great Britain and Northern Ireland”;
in paragraph (2)(a), for “, either in full or in part; and” substitute—
“in respect of—
(i)Great Britain;
(ii)Northern Ireland; or
(iii)both Great Britain and Northern Ireland,
either in full or in part; and”.
Annotations
Textual amendments
- F1
Regs. 217A-217D inserted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 177
Commencement
- I1
Reg. 217C in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1